SEI Investments’s Corvus Pharmaceuticals CRVS Stock Holding History
Bought
Maintained
Sold
Other funds holding CRVS
O
ASP
VC
PA
DTC
SEI Investments's CRVS Position: Q2 2026 in Review
SEI Investments increased its Corvus Pharmaceuticals (CRVS) stake by 31% in Q2 2026, buying an estimated $266K and bringing the position to 80,006 shares worth $1.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2215.
SEI Investments first reported a position in CRVS in Q1 2026 and has held it in 2 quarters since. 173 funds tracked by Wall St. Rank hold CRVS as of Q2 2026.
- SEI Investments held 80,006 shares of Corvus Pharmaceuticals worth $1.2M as of Q2 2026.
- SEI Investments bought 19,158 Corvus Pharmaceuticals shares in Q2 2026, an estimated $266K.
- Corvus Pharmaceuticals made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #2215 holding.
- SEI Investments first reported a position in Corvus Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
- 173 funds tracked by Wall St. Rank held Corvus Pharmaceuticals as of Q2 2026.
Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.